IAVI Report

IAVI Report is a scientific publication that provides comprehensive and editorially independent coverage of HIV vaccine and prevention research, as well as the quest to develop vaccines and other preventive technologies to address other global health priorities. It features the voices and opinions of those leading these efforts and provides an unparalleled analysis of the latest scientific and policy research.

To access archived issues of IAVI Report dating back to 1996, click here.

Subscribe below to receive IAVI Report right to your inbox.

Questions/comments? Email us at iavireport@iavi.org.

Filter by

  • Health area

  • Locations

  • Topic

  • Year

  • Journal

  • Clear all

IAVI Report

Data cabinets in the cloud

July 20, 2022

Clinical research data is precious. The IAVI DataSpace platform seeks better ways to store, manage, and share this information securely so it can be used to advance medical research.

Read more

IAVI Report

Can mRNA manufacturing become more global?

June 21, 2022

With pluck, persistence, and scientific prowess, more countries are gearing up to develop and produce the vaccines of the future.

Read more

IAVI Report

Is the next pandemic preventable?

June 8, 2022

COVID-19 has inspired many books about pandemic prevention, but reports show the world isn’t any better prepared today than it was before.

Read more

IAVI Report

Persistence pays: Researchers unravel mechanism of protection for a potential HIV vaccine vector

May 25, 2022

Scientists explain why a cytomegalovirus-vectored vaccine candidate, nearly 20 years in the making, produces promising results in monkeys. Will the same be true in humans?

Read more

IAVI Report

Jon Cohen on writing about COVID-19 and why we must prepare now for the next public health crisis

April 27, 2022

A conversation with Jon Cohen about what made writing about this pandemic different and what stories are still to be told.

Read more

IAVI Report

The future of mRNA-based HIV vaccines is about more than speed

April 27, 2022

Right now in vaccine research, mRNA has the momentum. For HIV, there are currently several formulations of experimental vaccines in early-stage human clinical trials. Apart from some overlap in strategy, they have one main thing in common — they rely on mRNA. This trend reflects the intense overall interest in mRNA-based vaccine development, given its…

Read more

IAVI Report

From the editor — a new IAVI Report

April 27, 2022

After 25 years of IAVI Report, we’re making a few changes. In 2020, life changed for many across the globe. As SARS-CoV-2 began its deadly march through humankind, countries entered lockdown, offices and schools closed, and many of us who weren’t on the so-called front lines of the pandemic were largely sheltered within our homes.…

Read more

IAVI Report

The global stakes for vaccine access

December 20, 2021

COVID-19 has made stark inequities in global access to vaccines, drugs, and diagnostics more visible and alarming than ever.

Read more

IAVI Report

Vaccinology reaches a new peak

December 20, 2021

Stanley Plotkin discusses the greatest progress in vaccine development in more than half a century and the lingering barriers to an effective HIV vaccine.

Read more

IAVI Report

What next? HIV science (again) at a turning point

December 20, 2021

After four decades of HIV research, the field seeks to make progress against one of the most difficult pathogens vaccine researchers have ever faced.

Read more

IAVI Report

40 years of AIDS vaccine research

December 20, 2021

A timeline of major milestones in the decades-long effort to develop an HIV vaccine.

Read more

IAVI Report

The past, present, and future of IAVI

December 20, 2021

In conversation with IAVI founder Seth Berkley and CEO Mark Feinberg

Read more